Signaling: Focus on Rho in renal disease

被引：42

作者：

Sharpe, CC ^{[1
]}

Hendry, BM ^{[1
]}

机构：

[1] Kings Coll London, Dept Renal Med, Guys Kings & St Thomas Sch Med, London SE5 9PJ, England

来源：

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2003年 / 14卷 / 01期

关键词：

D O I：

10.1097/01.ASN.0000048223.05219.E4

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

引用

页码：261 / 264

页数：4

共 37 条

[1]

p21WAF1/CIP1 is upregulated by the geranylgeranyltransferase I inhibitor GGTI-298 through a transforming growth factor β- and Sp1-responsive element:: Involvement of the small GTPase RhoA [J].

Adnane, J ;

Bizouarn, FA ;

Qian, YM ;

Hamilton, AD ;

Sebti, SM .

MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (12) :6962-6970

[2]

Inhibition of TGF-beta 1 expression by antisense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis [J].

Akagi, Y ;

Isaka, Y ;

Arai, M ;

Kaneko, T ;

Takenaka, M ;

Moriyama, T ;

Kaneda, Y ;

Ando, A ;

Orita, Y ;

Kamada, T ;

Ueda, N ;

Imai, E .

KIDNEY INTERNATIONAL, 1996, 50 (01) :148-155

[3]

Rho signals to cell growth and apoptosis [J].

Aznar, S ;

Lacal, JC .

CANCER LETTERS, 2001, 165 (01) :1-10

[4]

Searching new targets for anticancer drug design: The families of Ras and Rho GTPases and their effectors [J].

Aznar, S ;

Lacal, JC .

PROGRESS IN NUCLEIC ACID RESEARCH AND MOLECULAR BIOLOGY, VOL 67, 2001, 67 :193-234

[5]

Rho GTPases and their effector proteins [J].

Bishop, AL ;

Hall, A .

BIOCHEMICAL JOURNAL, 2000, 348 (02) :241-255

[6]

Transforming growth factor-β in renal disease [J].

Bitzer, M ;

Sterzel, RB ;

Böttinger, EP .

KIDNEY & BLOOD PRESSURE RESEARCH, 1998, 21 (01) :1-12

[7]

3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation [J].

Blanco-Colio, LM ;

Villa, A ;

Ortego, M ;

Hernández-Presa, MA ;

Pascual, A ;

Plaza, JJ ;

Egido, J .

ATHEROSCLEROSIS, 2002, 161 (01) :17-26

[8]

BOS JL, 1989, CANCER RES, V49, P4682

[9]

Rho-kinase inhibition blunts renal vasoconstriction induced by distinct signaling pathways in vivo [J].

Cavarape, A ;

Endlich, N ;

Assaloni, R ;

Bartoli, E ;

Steinhausen, M ;

Parekh, N ;

Endlich, K .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (01) :37-45

[10]

Chen RH, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134887

← 1 2 3 4 →